Type 1 diabetes research watch: recent papers and DOI records worth sorting
A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
The evidence posture
Research records are not all equal. A PubMed or DOI record may represent a clinical study, review, device paper, mechanistic finding, animal study, or early-stage idea. The job of this page is to surface the source and keep the evidence label visible.
The highest-value Type 1 diabetes watch topics include beta-cell replacement, islet biology, immune modulation, automated insulin delivery, CGM performance, hypoglycemia, pediatric care, and quality-of-life outcomes.
Recent research records
- Engineering a bijel-templated material-integrated cannula for subcutaneous insulin delivery: Design, fabrication, in vivo delivery characterization, and failure analysis. — Biomaterials advances. Authors: Groisman L, Thorson TJ, Saudi B. Journal ArticleSource
- Retrievable "sea-island" microstructured zwitterionic-silicone hydrogel devices: augmented oxygen transport and anti-fibrosis for sustaining islet survival. — Bioactive materials. Authors: Chen D, Wang H, Tang Y. Journal ArticleSource
- IFNα and bleomycin-induced DNA damage activate distinct stress responses in human islets and induced pluripotent stem cell-derived islet cells. — Islets. Authors: Akbari Motlagh R, Rampazzo Morelli N, Alcasid N. Journal ArticleSource
- Human and mouse regenerative macrophages enhance beta cell survival, function, and proliferation. — Islets. Authors: Monajemi M, Craciun AS, Huang Q. Journal ArticleSource
- Is the intraportal or renal subcapsular space a preferable site for islet allo- and xeno-transplantation? A brief historical review. — Islets. Authors: De Taeye S, Bottino R, Cooper DKC. Journal Article, ReviewSource
- MLPH/RAB3A accelerates the differentiation of pancreatic stem cells to islet β-cells to control blood glucose in diabetic rats. — Organogenesis. Authors: Shan J, Wang H, Zhu G. Journal ArticleSource
- Treatment patterns, healthcare utilization, and healthcare costs in patients with newly diagnosed type 1 diabetes: a retrospective real-world study in Tianjin, China. — Journal of medical economics. Authors: Liu W, Ji L, Chen Y. Journal ArticleSource
- Deletion of the T1D risk gene Ormdl3 in β-cells does not impact disease progression. — Biochemistry and biophysics reports. Authors: Ou Q, Jones EF, Currey K. Journal ArticleSource
- Glutamate-glutamine axis in pancreatic β-cells: mechanistic insights and therapeutic prospects in diabetes and its complications. — Journal of diabetes and metabolic disorders. Authors: Olatunde A, Disina HB, Eyitayo AR. Journal Article, ReviewSource
What needs editorial review
- Whether the record is human clinical evidence, preclinical work, review material, device performance data, or commentary.
- Whether outcomes matter to families: A1C, time in range, severe hypoglycemia, DKA, sleep, school, sports, treatment burden, and durability.
- Whether a company, sponsor, or press release is driving the claim before independent evidence exists.
This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.